T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.05% |
| 2 | Consumer Discretionary | 13.82% |
| 3 | Financials | 13.14% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Chevron
CVX
$387B
| $1.52B | 0.31% |
14,515,479
-668,593
| -4% | -$71.4M |
|
77
Range Resources
RRC
$9.41B
| $1.51B | 0.31% |
29,035,929
-724,530
| -2% | -$35.9M |
|
78
Eli Lilly
LLY
$1.09T
| $1.5B | 0.31% |
20,614,987
-3,560,911
| -15% | -$254M |
|
79
Citigroup
C
$231B
| $1.49B | 0.31% |
28,941,752
+1,064,636
| +4% | +$54.2M |
|
80
FedEx
FDX
$77.1B
| $1.49B | 0.31% |
9,009,939
+496,772
| +6% | +$86.3M |
|
81
Honeywell
HON
$74.3B
| $1.48B | 0.31% |
15,783,825
-1,334,375
| -8% | -$122M |
|
82
Crown Castle
CCI
$31.5B
| $1.48B | 0.31% |
17,904,457
-4,970,536
| -22% | -$423M |
|
83
Qualcomm
QCOM
$171B
| $1.48B | 0.3% |
21,290,872
+519,758
| +3% | +$36.6M |
|
84
Agilent Technologies
A
$41.9B
| $1.47B | 0.3% |
35,447,313
-25,627
| -0.1% | -$1.04M |
|
85
Cisco
CSCO
$486B
| $1.45B | 0.3% |
52,732,330
-8,684,994
| -14% | -$244M |
|
86
Tractor Supply
TSCO
$19B
| $1.45B | 0.3% |
84,982,350
-6,062,620
| -7% | -$101M |
|
87
MGM Resorts International
MGM
$11.1B
| $1.42B | 0.29% |
67,583,605
+3,460,300
| +5% | +$72.4M |
|
88
MetLife
MET
$61.5B
| $1.42B | 0.29% |
31,485,747
+1,875,797
| +6% | +$84.3M |
|
89
Canadian Natural Resources
CNQ
$98.6B
| $1.39B | 0.29% |
93,365,847
+31,078,264
| +50% | +$445M |
|
90
APA Corp
APA
$14.2B
| $1.35B | 0.28% |
22,307,081
-4,063,006
| -15% | -$256M |
|
|
TYC
91
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
| $1.34B | 0.28% |
29,771,967
+7,221,854
| +32% | +$322M |
|
92
PG&E
PCG
$38.2B
| $1.33B | 0.27% |
25,054,376
-2,047,751
| -8% | -$113M |
|
93
US Bancorp
USB
$101B
| $1.31B | 0.27% |
29,940,756
-334,944
| -1% | -$14.7M |
|
94
Texas Instruments
TXN
$254B
| $1.3B | 0.27% |
22,797,077
-4,209,874
| -16% | -$236M |
|
95
Carnival Corporation Ltd
CCL
$38.1B
| $1.28B | 0.26% |
26,761,753
-4,517,665
| -14% | -$203M |
|
96
Wabtec
WAB
$50B
| $1.27B | 0.26% |
13,369,078
-95,254
| -0.7% | -$8.59M |
|
|
DD
97
DELISTED
Du Pont De Nemours E I
DD
| $1.26B | 0.26% |
18,612,876
+12,229,880
| +192% | +$873M |
|
|
TWTR
98
DELISTED
Twitter, Inc.
TWTR
| $1.25B | 0.26% |
24,983,035
+10,846,879
| +77% | +$481M |
|
99
Johnson Controls International
JCI
$93.6B
| $1.23B | 0.25% |
23,231,089
+5,313,807
| +30% | +$270M |
|
100
Kohl's
KSS
$2.15B
| $1.21B | 0.25% |
15,410,141
-3,346,164
| -18% | -$228M |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.